| Noradrenergic alterations in Parkinson’s disease: a combined 11C-yohimbine PET/neuromelanin MRI study C Laurencin, S Lancelot, S Brosse, I Mérida, J Redouté, E Greusard, ... Brain 147 (4), 1377-1388, 2024 | 7 | 2024 |
| Opportunities and Pitfalls of REM Sleep Behavior Disorder and Olfactory Dysfunction as Early Markers in Parkinson’s Disease B Orso, S Brosse, J Frasnelli, D Arnaldi Journal of Parkinson's Disease, 1-11, 2024 | 2 | 2024 |
| Troubles chimiosensoriels causés par la Covid-19: effets à long terme et piste d’une solution C Zigrand, S Brosse, N Bouguiyoud, S Bérubé, N Bussière, J Frasnelli Annales des Mines-Responsabilité et environnement, 27-30, 2022 | | 2022 |
| Evidence of the involvement of the white matter integrity in olfactory dysfunctions in Parkinson's disease S Brosse, C Tremblay, I Merida, J Frasnelli CHEMICAL SENSES 47, 2022 | | 2022 |
| First in vivo evidence of the involvement of the noradrenergic system in age-related olfactory dysfunctions in healthy humans S Brosse, C Laurencin, N Costes, I Merida, B Ballanger CHEMICAL SENSES 46, 2021 | | 2021 |
